Cencora solution

FormularyDecisions® for biopharma companies

Exchange information with thousands of healthcare decision-makers and connect with the largest active online healthcare decision-maker community in the U.S. to share information throughout your product's lifecycle.
Tilgjengelig for
  • Farmasøytiske produsenter
  • Helsevesen

Discover more

Contact sales

Whether you have questions about our capabilities or need more information, our experts are here to assist you. 

Maximize brand visibility

FormularyDecisions is a secure, online platform facilitating the bidirectional exchange of information between biopharma companies and active healthcare decision-makers representing over 298 million pharmacy benefit manager covered lives in the US.

From pre-approval to post-launch, get unrivaled insight into what healthcare decision-makers think of your product and those of your competitors, and gain feedback to better inform your market access strategies.
Available in English only

Proaktiv deling av e-dossierer for ikke-godkjent produkt og ikke-godkjent bruk

I tråd med FDAs 2022 Pre-Approval Information Exchange (PIE) Act, har FormularyDecisions introdusert en ny funksjon som lar biofarmasøytiske selskaper proaktivt dele ikke-godkjente produkter og ikke-godkjent bruk e-dossierer. Når denne funksjonaliteten er aktivert, trenger ikke beslutningstakere i helsevesenet lenger å sende inn tilgangsforespørsler via eRequest-systemet vårt, noe som forenkler gjennomgangen av tilgjengelig informasjon før potensielle produkt- og indikasjonsbeslutninger.  

Hvis du vil utforske denne nye funksjonaliteten, kan du gjerne kontakte oss: 

Introducing "Product Perspectives"

Every biopharma company is unique, which is why the FormularyDecisions platform is customizable for small, medium, and large biopharma companies. From acting as an extension of your field team to effectively communicating the value of your diverse product portfolio, FormularyDecisions is equipped to help you streamline and optimize healthcare decision-maker engagement, giving you the competitive edge you need.

"Product Perspectives" is a new offering designed to equip biopharma subscribers with deeper insights into how healthcare decision-makers perceive their product and the broader market landscape.

Drive healthcare decision-maker activity vs your competitors

Boost your digital engagement strategy with a unified platform. Nearly all surveyed healthcare decision-makers highlight the need for biopharma companies to blend traditional and digital channels for effective communication. With healthcare decision-maker activity on FormularyDecisions increasing eightfold in the past five years, optimize your approach and connect more effectively today.

FormularyDecisions er en pålitelig AMCP-partner

AMCP er den profesjonelle foreningen som leder an for å hjelpe pasienter med å få medisinene de trenger til en pris de har råd til.

AMCPs mangfoldige medlemskap av farmasøyter, leger, sykepleiere, biofarmasøytiske fagfolk og andre interessenter utnytter sin spesialiserte ekspertise innen klinisk evidens og økonomi for å optimalisere design av medisinfordeler og befolkningshelsestyring og hjelpe pasienter med å få tilgang til kostnadseffektive og trygge medisiner og andre medikamentelle terapier. AMCP-medlemmer forbedrer livene til nesten 300 millioner amerikanere betjent av private og offentlige helseplaner, apotekfordelsstyringsfirmaer og nye omsorgsmodeller.

Explore our webinar library

View our curated collection of informative webinars that cover a wide range of healthcare topics. Stay current with the latest sessions by registering for upcoming webinars and accessing past recordings.
 

Connect with our experts

Reach healthcare decision-makers like never before

FormularyDecisions is a secure online platform facilitating the bi-directional exchange of information between biopharma companies and active healthcare decision-makers. From pre-approval to post-launch, subscribing organizations get unrivaled insight into payers perception of their products and those of industry competitors, and gain feedback to better inform market access strategies.

Because every biopharma company is unique, the FormularyDecisions platform is highly customizable. Enterprise users often host multiple products at once, and strategic consulting assists subscribing companies in efficiently customizing their platform so they can drive more effective healthcare decision-makers engagement and maintain a competitive edge.